Evidence map›Paper›PMID 35339728›Full record

ArticleMolecular metabolism2022

Hypothalamic Irak4 is a genetically controlled regulator of hypoglycemia-induced glucagon secretion.

Alexandre Picard, Xavier Berney, Judit Castillo-Armengol, David Tarussio, Maxime Jan, Ana Rodriguez Sanchez-Archidona, Sophie Croizier, Bernard Thorens

Open access · goldAbstract read
In one paragraph

Article in Molecular metabolism, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
2.2field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

Alexandre PicardCenter for Integrative Genomics, University of Lausanne, 1015, Lausanne, Switzerland.
Xavier BerneyCenter for Integrative Genomics, University of Lausanne, 1015, Lausanne, Switzerland.
Judit Castillo-ArmengolCenter for Integrative Genomics, University of Lausanne, 1015, Lausanne, Switzerland; Novo Nordisk A/S, Måløv, Denmark.
David TarussioCenter for Integrative Genomics, University of Lausanne, 1015, Lausanne, Switzerland.
Maxime JanCenter for Integrative Genomics, University of Lausanne, 1015, Lausanne, Switzerland.
Ana Rodriguez Sanchez-ArchidonaCenter for Integrative Genomics, University of Lausanne, 1015, Lausanne, Switzerland.
Sophie CroizierCenter for Integrative Genomics, University of Lausanne, 1015, Lausanne, Switzerland.
Bernard ThorensCenter for Integrative Genomics, University of Lausanne, 1015, Lausanne, Switzerland. Electronic address: bernard.thorens@unil.ch.
University of Lausanne · CHNovo Nordisk (Denmark) · DK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesGlucagon secretion to stimulate hepatic glucose production is the first line of defense against hypoglycemia. This response is triggered by so far incompletely characterized central hypoglycemia-sensing mechanisms, which control autonomous nervous activity and hormone secretion. The objective of this study was to identify novel hypothalamic genes controlling insulin-induced glucagon secretion.

methodsTo obtain new information on the mechanisms of hypothalamic hypoglycemia sensing, we combined genetic and transcriptomic analysis of glucagon response to insulin-induced hypoglycemia in a panel of BXD recombinant inbred mice.

resultsWe identified two QTLs on chromosome 8 and chromosome 15. We further investigated the role of Irak4 and Cpne8, both located in the QTL on chromosome 15, in C57BL/6J and DBA/2J mice, the BXD mouse parental strains. We found that the poor glucagon response of DBA/2J mice was associated with higher hypothalamic expression of Irak4, which encodes a kinase acting downstream of the interleukin-1 receptor (Il-1R), and of Il-ß when compared with C57BL/6J mice. We showed that intracerebroventricular administration of an Il-1R antagonist in DBA/2J mice restored insulin-induced glucagon secretion; this was associated with increased c-fos expression in the arcuate and paraventricular nuclei of the hypothalamus and with higher activation of both branches of the autonomous nervous system. Whole body inactivation of Cpne8, which encodes a Ca

conclusionsCollectively, our data identify Irak4 as a genetically controlled regulator of hypoglycemia-activated hypothalamic neurons and glucagon secretion.

Indexed as

GlucagonHypoglycemiaHypothalamusInterleukin-1 Receptor-Associated KinasesAnimalsInsulinMiceMice, Inbred C57BLMice, Inbred DBAGlucagonInsulinInterleukin-1 Receptor-Associated KinasesIrak4 protein, mouseAutonomous nervous systemGenetic screeningGlucagonHypothalamusInsulin-induced hypoglycemia

Identifiers

PMID35339728
PMCPMC9046887
OpenAlexW4221119914

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.